Clinical update

Non-Hodgkin’s lymphoma

Your essential guide to signs, symptoms, treatment and the latest guidelines on Non-Hodgkin's lymphoma

Essential facts

Non-Hodgkin’s lymphoma (NHL) is a cancer of the lymphatic system. According to Cancer Research UK, it is the sixth most common cancer in the UK, with 13,413 new cases diagnosed in 2013. There were 4,801 deaths from NHL in 2014. Although there are many different subtypes of the disease, there are two broad categories: high grade or aggressive and low grade or indolent.

Picture: SPL
What’s new

In July 2016, the National Institute for Health and Care Excellence (NICE) published new guidance on NHL, which addressed a number of areas where there is uncertainty or variation in clinical practice. It includes recommendations on diagnosis and the most effective treatments and management for six of the more common subtypes: follicular lymphoma, MALT lymphoma, mantle cell lymphoma, diffuse large B-cell lymphoma, Burkitt lymphoma and peripheral T-cell lymphoma. Improved understanding of the disease’s biology is leading to


Want to read more?

Unlock full access to RCNi Plus today

Save over 50% on your first three months:

  • Customisable clinical dashboard featuring 200+ topics
  • Unlimited online access to all 10 RCNi Journals including Nursing Standard
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • NMC-compliant RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests

This article is not available as part of an institutional subscription. Why is this?